U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel) -

U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A medical food is specifically formulated for patients, who require medical food as a major part of their dietary supplement during treatment. Medical foods are available in different forms such as powders, liquids, and even gum. Although medical foods can be used as acute care therapy in prehospital care, short-term stabilization and it can be administered enteral during an inpatient visit. Moreover, medical foods are more commonly used to treat chronic conditions and diseases through long-term use in an outpatient setting.
Market Dynamics
Medical foods are also used in the treatment of other gastrointestinal diseases such as diarrhea, constipation, gastroenteritis, peptic ulcer diseases, and colorectal cancer, which is expected to propel market growth over the forecast period. For instance in July 2021, Georgetown University entered into a collaboration with National Center for Complementary and Integrative Health (NCCIH) University of Maryland, Baltimore initiated early phase 1 clinical trial to demonstrate the mechanisms of preventing antibiotic-associated diarrhea and the role of probiotics.
Key features of the study:
This report provides in-depth analysis of the U.S. medical foods market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It provides key players in the U.S. medical foods market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up gradation, market expansion, and marketing tactics
The U.S. medical foods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. medical foods market
Detailed Segmentation:
U.S. Medical Foods Market, By Food Type:
Prebiotics
Probiotics
Probiotic Foods
Probiotic Supplements
Food Supplements
U.S. Medical Foods Market, By Disease Indication:
Inflammatory Bowel Disease
Ulcerative Colitis
Cohn’s Disease
Irritable Bowel Syndrome
Others
U.S. Medical Foods Market, By Distribution Channel:
Hospitals
Retail Channel
Online Channel
Company Profiles
Enterome SA*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Market Strategies
Yakult Honsha Co., Ltd.
Abbott
ExeGi Pharma, LLC.
VSL Pharmaceuticals, Inc.
Entera Health, Inc.
Meiji Holdings Co., Ltd.
Danone
Nestlé S.A.
“*” marked represents similar segmentation in other categories in the respective section.